Synapse-Related Serum and P300 Biomarkers Predict the Occurrence of Mild Cognitive Impairment in Depression
Zongwei Xue,Xiaoyan Zhu,Wenqi Wu,Yan Zhu,Yuhao Xu,Ming Yu
DOI: https://doi.org/10.2147/ndt.s448312
IF: 2.989
2024-03-06
Neuropsychiatric Disease and Treatment
Abstract:Zongwei Xue, 1, &ast Xiaoyan Zhu, 2– 4, &ast Wenqi Wu, 1 Yan Zhu, 5 Yuhao Xu, 1 Ming Yu 1 1 Department of Neurology, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, People's Republic of China; 2 Department of Neurology, People's Hospital of Yangzhong City, Yangzhong, Jiangsu, 212299, People's Republic of China; 3 School of Clinical Medicine, Medical College of Yangzhou University, Yangzhou, Jiangsu, 225000, People's Republic of China; 4 Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou, Jiangsu, 225000, People's Republic of China; 5 Department of Radiology, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu, 212001, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yuhao Xu; Ming Yu, Department of Neurology, The Affiliated Hospital of Jiangsu University, No. 438 Jiefang Road, Zhenjiang, 212001, People's Republic of China, Tel +86 187 9601 7221, Email ; Background: Cognitive impairment is one of the common concomitant symptoms of depression. The aims of the present study were to predict the occurrence of mild cognitive impairment (MCI) in patients with depression. Methods: In this study, 217 patients with depression were recruited. Demographic data, serum indices and ERP indices from all participants were collected in the baseline period. The participants were followed for one year, and data from 200 patients were included in final analysis. Patients with depression were divided into those with MCI group (DWM group; n=145) and those without MCI (DWOM group; n=55). Data from the DWM group and the DWOM group were used to construct a logistic regression model, and a receiver operating characteristic (ROC) curve was drawn. Another 72 patients were used to validate the accuracy of our model. Results: Compared with DWOM individuals, DWM individuals were more likely to live alone (P< 0.05), had lower baseline serum levels of brain-derived neurotrophic factor (BDNF), fibroblast growth factor 2 (FGF2), and fibroblast growth factor 22 (FGF22) (P< 0.05), and exhibited higher baseline latencies of P300, mismatch negativity (MMN), and N200 (P< 0.05). Baseline serum BDNF and FGF22 levels, along with the P300 latency, were selected to construct the regression model using logistic regression. The regression equation was , and the combination of the 3 indices yielded an area under the ROC curve (AUC) of 0.790 and a predictive accuracy of 0.806. Conclusion: The logistic regression model and ROC curves based on serum BDNF and FGF22 levels and the P300 latency could provide a more effective means to predict the occurrence of MCI in patients with depression. Keywords: depression, mild cognitive impairment, brain-derived neurotrophic factor, fibroblast growth factor 22, P300, prediction Depression is a highly prevalent psychological disorder characterized by a persistently depressed mood, and has diverse clinical manifestations dominated by affective and cognitive impairment. 1 Cognitive deficits in depression can lead to impaired functioning in four areas, including executive function, attention, memory and information processing speed, which not only hinder the effectiveness and cure rate of antidepressant treatment and increases the risk of recurrence of depression, but also hinder some depressed individuals from returning to normal social functioning. 2–4 However, in the clinical diagnosis and treatment of depression, the cognitive impairments are overlooked. Cognitive deficits are widespread in the course of depression and can occur before the occurrence of depression or during episodes of depression or can persist after the episode of depression has resolved. 5,6 Cognitive symptoms are major contributors to dysfunction in people with chronic depression who still participate in the workforce but unable to return to their previous levels of performance after recovery. 7 A growing body of research suggests that cognitive symptoms, both subjective (self-reported) and objective (assessed using neuropsychological tests), are independently associated with different forms of functional impairment in patients with depression and that improvement in cognitive symptoms can reduce the degree of disability in patients. 8 However, current interventions for cognitive impairment are limited, and available pharmacologic and nonpharmacologic treatments provide little benefit to patients after cognitive impairment has occurred. Therefore, early screening for cognitive impairment in -Abstract Truncated-
psychiatry,clinical neurology